Author | Andrew John Li, MD


What’s new in biomarker testing for ovarian cancer

April 10, 2019

Three tests are now FDA-approved for triaging pelvic masses in asymptomatic women. 

Letters to the Editor

July 01, 2012

Letters discuss the myriad of issues affecting the practice of specialties. Joshua A. Copel responds.

Letters to the Editor

June 01, 2012

Letters discuss global endometrial ablations, intrauterine scarring, and disagreements over cancer biomarkers. Steven R. Goldstein and Andrew John Li respond.